Waterfront Wealth Inc.
Source: SEC Form 13F · as of Mar 2026Waterfront Wealth Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $23.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$23.8M
| Company | Shares | Value |
|---|---|---|
| AMRNAMARIN CORP PLCUK | 203,338 | $2.9M |
| JAZZJazz Pharmaceuticals plc | 15,382 | $2.9M |
| SNYSanofi | 60,042 | $2.9M |
| VTRSViatris Inc | 193,841 | $2.6M |
| ABBVAbbVie Inc. | 10,466 | $2.3M |
| BMYBRISTOL MYERS SQUIBB CO | 33,159 | $2.0M |
| ZTSZoetis Inc. | 11,395 | $1.3M |
| GMOptec International, Inc. | 17,952 | $1.3M |
| QGENQIAGEN N.V. | 26,221 | $1.0M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,169 | $969K |
| JNJJOHNSON & JOHNSON | 3,073 | $751K |
| LNTHLantheus Holdings, Inc. | 9,843 | $747K |
| BIIBBIOGEN INC. | 2,747 | $504K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,812 | $490K |
| PFEPFIZER INC | 16,279 | $457K |
| LLYELI LILLY & Co | 276 | $254K |
| MRKMerck & Co., Inc. | 2,040 | $245K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.